Adrian Quartel
Hoofd Techniek/Wetenschap/O&O bij ZEVRA THERAPEUTICS, INC.
Actieve functies van Adrian Quartel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ZEVRA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 04-01-2024 | - |
Loopbaan van Adrian Quartel
Eerdere bekende functies van Adrian Quartel
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACER THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 22-02-2022 | 01-01-2023 |
ADAMAS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2020 | 01-02-2022 |
BIOMARIN PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2016 | 01-09-2020 |
Opleiding van Adrian Quartel
Erasmus University Rotterdam | Doctorate Degree |
The Royal College of Physicians | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Nederland | 2 |
Verenigd Koninkrijk | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 4 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
ZEVRA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Acer Therapeutics, Inc.
Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
- Beurs
- Insiders
- Adrian Quartel
- Ervaring